LEBLAUF Webside schaefer - Kliniken Essen-Mitte

33. Schaefer M, Schwaiger M, Pich M, Lieb K, Heinz A. Neurotransmitter changes by
Interferon-alpha and therapeutic implications. Pharmacopsychiatry 2003; 36
(suppl.3):S255-258 IF: 2.777
34. Schiemann U, Glas J, Török P, Simperl C, Martin K, König A, Schmidt F, Schaefer M,
Folwaczny C. Response to combination therapy with Interferon alfa-2a and Ribavirin in
chronic hepatitis C according to a TNF-α promotor polymorphism. Digestion 2003; 68:1-
4 IF: 1.892
35. Glas J, Torok HP, Simperl C, König A, Martin K, Schmidt F, Schaefer M, Schiemann U,
Folwaczny C. The Delta 32 mutation of the chemokine-receptor 5 gene neither is
correlated with chronic hepatitis C nor does it predict response to therapy with interferonalpha
and ribavirin. Clinical Immunology 2003; 108(1):46-50. IF: 2.915
36. Henkel V, Mergl R, Schäfer M, Rujescu D, Möller HJ, Hegerl U. Kinematical analysis of
motor function in schizophrenic patients: a possibility to separate negative symptoms from
extrapyramidal dysfunction induced by neuroleptics? Pharmacopsychiatry 2004;
37(3):110-8. IF: 2.089
37. Schaefer M. Schmidt F., Horn M., Schmid-Wendtner MH, Volkenandt M. Depression
during treatment with Interferon-alpha. Psychosomatics. 2004; 45(2):176 IF: 2.115
38. Schaefer M, Horn M, Schmidt F, Schmid-Wendtner M.H., Volkenandt M, Ackenheil M,
Mueller N, Schwarz M.J. Correlation between sICAM-1 and depressive symptoms during
adjuvant treatment of melanoma with Interferon-α. Brain Behavior and Immunity 2004;
18(6): 555-562 IF: 2.937
39. Schaefer M, Heinz A, Backmund M. Treatment of chronic hepatitis C in patients with
drug dependence: time to change the rules? Addiction 2004; 99: 1167-1175 IF: 3.006
40. Schaefer M, Schwaiger M, Garkisch AS, Pich M, Hinzpeter A, Uebelhack R, Heinz A,
van Boemmel, F, Berg T. Prevention of Interferon-alpha associated depression in
psychiatric risk patients with chronic hepatitis C. Journal of Hepatology 2005; 42: 793-
798 IF: 6.073
41. Schäfer M. Psychiatrische Nebenwirkungen unter Interferon-alpha. INFO Neurologie &
Psychiatrie 2005; 7: 46-53
42. Schäfer M. Therapie der chronischen Hepatitis C bei Patienten mit psychischen
Erkrankungen. Suchttherapie 2005; 6:66-69
43. Schäfer M, Berg T. Die chronische Hepatitis C Infektion: Häufigkeit, Verlauf und Stand
der Behandlungsmöglichkeiten bei Patienten mit intravenöser Drogenabhängigkeit. Sucht
2005; 51(2):97-108
44. Schaefer M, TRATAMIENTO DE LA HEPATITIS C CRONICA EN PACIENTES EN
RIESGO DE PADECER ENFERMEDADES PSIQUIATRICAS (Treatment of chronic
hepatitis C in psychiatric risk patients). Published as from April 14th, 2005, on
www.siicsalud.com (ISSN: 1667-9008), Section Expertos Invitados, Expertos del Mundo,
10